Pfizer Inc. (PFE)
27.98
-0.04
(-0.14%)
USD |
NYSE |
Aug 28, 10:14
Pfizer Cash from Operations (Quarterly) : 835.00M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 835.00M |
| March 31, 2026 | 2.615B |
| December 31, 2025 | 5.349B |
| September 30, 2025 | 4.603B |
| June 30, 2025 | -582.00M |
| March 31, 2025 | 2.335B |
| December 31, 2024 | 6.721B |
| September 30, 2024 | 6.714B |
| June 30, 2024 | -1.782B |
| March 31, 2024 | 1.091B |
| December 31, 2023 | 5.24B |
| September 30, 2023 | 3.456B |
| June 30, 2023 | -1.207B |
| March 31, 2023 | 1.211B |
| December 31, 2022 | 8.582B |
| September 30, 2022 | 9.935B |
| June 30, 2022 | 8.169B |
| March 31, 2022 | 6.541B |
| December 31, 2021 | 5.914B |
| September 30, 2021 | 10.84B |
| June 30, 2021 | 11.28B |
| March 31, 2021 | 4.546B |
| December 31, 2020 | 5.625B |
| September 30, 2020 | 2.089B |
| June 30, 2020 | 3.556B |
| Date | Value |
|---|---|
| March 31, 2020 | 3.133B |
| December 31, 2019 | 3.769B |
| September 30, 2019 | 4.51B |
| June 30, 2019 | 2.611B |
| March 31, 2019 | 1.698B |
| December 31, 2018 | 4.738B |
| September 30, 2018 | 5.259B |
| June 30, 2018 | 3.847B |
| March 31, 2018 | 1.983B |
| December 31, 2017 | 7.074B |
| September 30, 2017 | 4.904B |
| June 30, 2017 | 3.233B |
| March 31, 2017 | 1.591B |
| December 31, 2016 | 5.752B |
| September 30, 2016 | 4.735B |
| June 30, 2016 | 3.605B |
| March 31, 2016 | 1.809B |
| December 31, 2015 | 4.713B |
| September 30, 2015 | 5.024B |
| June 30, 2015 | 4.091B |
| March 31, 2015 | 684.00M |
| December 31, 2014 | 5.397B |
| September 30, 2014 | 4.464B |
| June 30, 2014 | 4.087B |
| March 31, 2014 | 2.935B |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Johnson & Johnson | 8.616B |
| Eli Lilly & Co. | 10.69B |
| Merck & Co., Inc. | 5.37B |
| Bristol Myers Squibb Co. | 3.393B |
| Viatris, Inc. | 381.80M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 2.106B |
| Cash from Financing (Quarterly) | -3.663B |
| Free Cash Flow | 10.99B |
| Free Cash Flow Per Share (Quarterly) | 0.053 |
| Free Cash Flow to Equity (Quarterly) | 1.563B |
| Free Cash Flow to Firm (Quarterly) | 553.27M |
| Free Cash Flow Yield | 6.88% |